Pharmacokinetics, Safety, and Efficacy of Dolutegravir Dispersible Tablets in Young Children Living With HIV

NCT05006170 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Pediatric HIV Infection

Interventions

DRUG: DTG DT 20 mg
DRUG: DTG DT 25 mg

Sponsor

Chulalongkorn University